Layer-specific retinal metrics modestly improve the identification of individuals with poor cardiovascular health, a study suggests.

First time the FDA has cleared an AI-driven device which has been specifically designed for use with breast cancer surgery.

Spryte Medical announced the commencement of enrollment in the INSYTE trial evaluating the company’s neuro-optical CT (nOCT) ...

A new cross-sector Eye Care Interoperability Steering Group has been established to accelerate the adoption of consistent ...

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced today that it has received U.S. Food and Drug ...

Spryte Medical , a pioneer in intravascular neuro imaging, today announced the successful enrollment of the first participants in the INSYTE trial at Baptist Health Jacksonville, which marks a major ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

Precision angioplasty also improves the accuracy of choosing the right stent size and length. Because the vessel measurements ...

Paracentral acute middle maculopathy is a highly specific OCT marker for biopsy-proven giant cell arteritis with ocular ischemic involvement.

Claire demonstrated a statistically significant reduction in patients with residual cancer post-surgery compared to the standard of care aloneSocial Capital's Chamath Palihapitiya highlights ...

Channel Yonko was sentenced to life without parole this week after jurors rejected her insanity defense in the October 2024 ...

Optical Coherence Tomography (OCT) remains an important diagnostic tool in ophthalmology for identifying optic nerve diseases and monitoring disease progression, but experts caution that it should not ...